136 related articles for article (PubMed ID: 34508828)
1. Improvement of hepatitis B vaccine to induce IFN-γ cytokine response: A new formulation.
Rahimkhani A; Haghighat S; Noorbazargan H; Mahdavi M
Microb Pathog; 2021 Nov; 160():105184. PubMed ID: 34508828
[TBL] [Abstract][Full Text] [Related]
2. Montanide ISA-720 and Naloxone in HBsAg Vaccine Formulation: Cytokine Profiling and Monitoring of Long-Lasting Humoral Immune Responses.
Mirzaee M; Haghighat S; Golkaran B; Asgarhalvaei F; Mirzaee R; Taghizadeh M; Savoji MA; Esfandiari B; Mahdavi M
Biomed Environ Sci; 2022 Sep; 35(9):792-803. PubMed ID: 36189994
[TBL] [Abstract][Full Text] [Related]
3. Formulation of HBsAg in Montanide ISA 51VG adjuvant: Immunogenicity study and monitoring long-lived humoral immune responses.
Savoji MA; Sereshgi MMA; Ghahari SMM; Asgarhalvaei F; Mahdavi M
Int Immunopharmacol; 2021 Jul; 96():107599. PubMed ID: 33848910
[TBL] [Abstract][Full Text] [Related]
4. The new nano-complex, Hep-c, improves the immunogenicity of the hepatitis B vaccine.
Fakharzadeh S; Kalanaky S; Hafizi M; Goya MM; Masoumi Z; Namaki S; Shakeri N; Abbasi M; Mahdavi M; Nazaran MH
Vaccine; 2013 May; 31(22):2591-7. PubMed ID: 23583463
[TBL] [Abstract][Full Text] [Related]
5. Oral administration of synthetic selenium nanoparticles induced robust Th1 cytokine pattern after HBs antigen vaccination in mouse model.
Mahdavi M; Mavandadnejad F; Yazdi MH; Faghfuri E; Hashemi H; Homayouni-Oreh S; Farhoudi R; Shahverdi AR
J Infect Public Health; 2017; 10(1):102-109. PubMed ID: 27026241
[TBL] [Abstract][Full Text] [Related]
6. RLJ-NE-299A: a new plant based vaccine adjuvant.
Khajuria A; Gupta A; Singh S; Malik F; Singh J; Suri KA; Satti NK; Qazi GN; Srinivas VK; Gopinathan ; Ella K
Vaccine; 2007 Mar; 25(14):2706-15. PubMed ID: 16872726
[TBL] [Abstract][Full Text] [Related]
7. Whole recombinant Hansenula polymorpha expressing hepatitis B virus surface antigen (yeast-HBsAg) induces potent HBsAg-specific Th1 and Th2 immune responses.
Bian G; Cheng Y; Wang Z; Hu Y; Zhang X; Wu M; Chen Z; Shi B; Sun S; Shen Y; Chen EJ; Yao X; Wen Y; Yuan Z
Vaccine; 2009 Dec; 28(1):187-94. PubMed ID: 19789093
[TBL] [Abstract][Full Text] [Related]
8. Nanocurcumin as an adjuvant in killed Toxoplasma gondii vaccine formulation: An experience in BALB/c mice.
Mahdi Ghahari SM; Ajami A; Sadeghizadeh M; Esmaeili Rastaghi AR; Mahdavi M
Exp Parasitol; 2022 Dec; 243():108404. PubMed ID: 36265591
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of hyaluronic acid-based combination adjuvant containing monophosphoryl lipid A and aluminum salt for hepatitis B vaccine.
Moon SH; Shin EC; Noh YW; Lim YT
Vaccine; 2015 Sep; 33(38):4762-9. PubMed ID: 26271830
[TBL] [Abstract][Full Text] [Related]
10. Platycodin D is a potent adjuvant of specific cellular and humoral immune responses against recombinant hepatitis B antigen.
Xie Y; Sun HX; Li D
Vaccine; 2009 Jan; 27(5):757-64. PubMed ID: 19041358
[TBL] [Abstract][Full Text] [Related]
11. Different Formulations of Inactivated SARS-CoV-2 Vaccine Candidates in Human Compatible Adjuvants: Potency Studies in Mice Showed Different Platforms of Immune Responses.
Haghighi M; Khorasani A; Karimi P; Keshavarz R; Mahdavi M
Viral Immunol; 2022 Dec; 35(10):663-672. PubMed ID: 36534465
[TBL] [Abstract][Full Text] [Related]
12. Formulation of a recombinant HIV-1 polytope candidate vaccine with naloxone/alum mixture: induction of multi-cytokine responses with a higher regulatory mechanism.
Fathi M; Nezamzadeh R; Abdollahpour-Alitappeh M; Yazdi MH; Khoramabadi N; Mahdavi M
APMIS; 2021 Aug; 129(8):480-488. PubMed ID: 33539574
[TBL] [Abstract][Full Text] [Related]
13. Formulation of HBs antigen in Montanide ISA266 shows superiority to commercial HBsAg vaccine in the induction of humoral immune responses.
Savoji MA; Haghighat S; Mirzaee M; Golkaran B; Mirzaee R; Esfandiari B; Mahdavi M
Gastroenterol Hepatol Bed Bench; 2019; 12(4):292-300. PubMed ID: 31749917
[TBL] [Abstract][Full Text] [Related]
14. PPD in HBsAg vaccine formulation suppressed IFN-γ and IL-4 cytokine responses and induced long-lived humoral immune responses: Results from 220-day monitoring of specific IgG responses.
Mirzaee R; Nemati F; Mirzaee M; Golkaran B; Khorasani A; Rashedi N; Asgarhalvaei F; Savoji MA; Mahdavi M
Iran J Basic Med Sci; 2022 Nov; 25(11):1326-1333. PubMed ID: 36474577
[TBL] [Abstract][Full Text] [Related]
15. Immunomodulatory Effects of
Eshraghi Y; Vahdani Y; Karimi P; Abdollahpour-Alitappeh M; Abdoli A; Taghizadeh M; Mahdavi M
Viral Immunol; 2022 Apr; 35(3):244-253. PubMed ID: 35467429
[TBL] [Abstract][Full Text] [Related]
16. Immune responses to HIV-1 polytope vaccine candidate formulated in aqueous and alcoholic extracts of Propolis: Comparable immune responses to Alum and Freund adjuvants.
Mojarab S; Shahbazzadeh D; Moghbeli M; Eshraghi Y; Bagheri KP; Rahimi R; Savoji MA; Mahdavi M
Microb Pathog; 2020 Mar; 140():103932. PubMed ID: 31857237
[TBL] [Abstract][Full Text] [Related]
17. [Enhancement of immune responses to hepatitis B DNA vaccine by superantigen SEA in mice].
Jin YW; Li P; Xu QB; Liu X; Huang W; Wang YL; Cao C; Ma QJ
Sheng Wu Gong Cheng Xue Bao; 2005 Sep; 21(5):681-5. PubMed ID: 16285504
[TBL] [Abstract][Full Text] [Related]
18. A new vaccine adjuvant (BOS 2000) a potent enhancer mixed Th1/Th2 immune responses in mice immunized with HBsAg.
Khajuria A; Gupta A; Malik F; Singh S; Singh J; Gupta BD; Suri KA; Suden P; Srinivas VK; Ella K; Qazi GN
Vaccine; 2007 Jun; 25(23):4586-94. PubMed ID: 17498851
[TBL] [Abstract][Full Text] [Related]
19. [Cellular immune responses of recombinant hepatitis B (rHB) vaccine and HBsAG derived from Hansenula polymorpha cells].
Hu ZY; He P; Zhang R; Fang X; Zhu FC; Qiu SH; Li HM; Wang H; Liang ZL; Zhuang H
Zhonghua Liu Xing Bing Xue Za Zhi; 2008 Jul; 29(7):706-11. PubMed ID: 19031766
[TBL] [Abstract][Full Text] [Related]
20. Poly(I:C)/alum mixed adjuvant priming enhances HBV subunit vaccine-induced immunity in mice when combined with recombinant adenoviral-based HBV vaccine boosting.
Chuai X; Chen H; Wang W; Deng Y; Wen B; Ruan L; Tan W
PLoS One; 2013; 8(1):e54126. PubMed ID: 23335993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
